ライフサイエンスコーパス: annuloplasty

1 f the mitral valve, and one had mitral valve annuloplasty).

2 residual IMR is likely after undersized ring annuloplasty.

3 tive TV deformation and residual TR after TV annuloplasty.

4 ension was not associated with outcome of TV annuloplasty.

5 had 2D echocardiography before and after TV annuloplasty.

6 ension was not associated with outcome of TV annuloplasty.

7 (LV) dilatation that is not relieved by ring annuloplasty.

8 icuspid regurgitation (TR) without tricuspid annuloplasty.

9 1,195 consecutive patients had MVR with ring annuloplasty.

10 one, whereas others favor concomitant mitral annuloplasty.

11 f moderate MR may warrant concomitant mitral annuloplasty.

12 ion (IMR), and the treatment effects of ring annuloplasty.

13 r partial (n=5) or Duran complete (n=6) ring annuloplasty.

14 The most common mitral repair was ring annuloplasty.

15 rolapse, perfusion time >90 min, and lack of annuloplasty.

16 in patients with IMR after restrictive ring annuloplasty.

17 ring from failure of mitral bioprosthesis or annuloplasty.

18 of mitral regurgitation following reduction annuloplasty.

19 an isolated edge-to-edge suture without any annuloplasty.

20 echniques are combined with traditional ring annuloplasty.

21 V regurgitation in the animal with the 28-mm annuloplasty.

22 n usually be effectively addressed with ring annuloplasty.

23 re associated with recurrent MR after mitral annuloplasty.

24 CABG with (n = 290) or without (n = 100) MV annuloplasty.

25 days), and >1 year (20+/-6 months) after TV annuloplasty.

26 area predicted early and mid-term outcome of annuloplasty.

27 ic determinants of mid-term outcome after TV annuloplasty.

28 Five sheep underwent surgical MV annuloplasty (24 mm, n = 2; 26 mm, n = 2; 28 mm, n = 1).

29 At 1 year after ring annuloplasty, 45 of 214 patients with MV repair (21%) ha

30 operative MR than those undergoing CABG + MV annuloplasty (48% vs. 12% at 1 year, p < 0.0001).

31 Transcatheter mitral cerclage annuloplasty acutely reduces mitral regurgitation in por

32 ion, as compared to restrictive mitral valve annuloplasty alone and to mitral valve replacement.

33 of the posterior leaflet may be helpful when annuloplasty alone is inadequate.

34 years, 23% of patients having CABG + mitral annuloplasty and 25% having CABG alone were in NYHA func

35 nce in any measure of remodeling between the annuloplasty and control groups.

36 Isolated annuloplasty and creation of double orifice mitral valve

37 Annuloplasty and repair techniques are used very effecti

38 and symptomatic improvement with restrictive annuloplasty and transcatheter edge-to-edge repair.

39 section or artificial chords with or without annuloplasty and was evaluated as a continuous variable

40 myxomatous changes in the MV, lack of mitral annuloplasty, and duration of cardiopulmonary bypass wer

41 pports the use of corrective tricuspid valve annuloplasty, and the growing consensus that FTR or tric

42 ntly higher in control animals than mesh and annuloplasty animals.

43 In contrast to ring annuloplasty, annular reduction sufficient to restore mi

44 utility of percutaneous leaflet repair, and annuloplasty approaches are undergoing significant devel

45 utility of percutanenous leaflet repair, and annuloplasty approaches are undergoing significant devel

46 ost rings currently used for tricuspid valve annuloplasty are formed in a single plane, whereas the a

47 the surgical edge-to-edge technique without annuloplasty are not satisfactory.

48 Adjunct surgical procedures, such as ring annuloplasty, are also necessary.

49 MR) is frequent despite initial reduction by annuloplasty because continued LV remodeling increases t

50 k was to determine whether mitral valve (MV) annuloplasty benefits patients with moderate/severe (3+/

51 l repairs have been more durable with use of annuloplasty, but recurrent regurgitation not resulting

52 ring second-order mitral chordae can improve annuloplasty by reducing papillary muscle tethering.

53 ted a rate of 6.5%, while restrictive mitral annuloplasty + CABG resulted in a rate of 4.1%.

54 illary muscle repair plus restrictive mitral annuloplasty +/- CABG and mitral valve replacement + CAB

55 illary muscle repair plus restrictive mitral annuloplasty +/- CABG has potential to reduce the risks

56 Percutaneous annuloplasty can be achieved indirectly via the coronary

57 ponent of the Bolling undersized mitral ring annuloplasty concept is to decrease LV wall stress by al

58 Restrictive mitral annuloplasty demonstrated a rate of 6.5%, while restrict

59 R with a dilated annulus may improve without annuloplasty despite dilated tricuspid annulus diameters

60 An annuloplasty device optimized to reduce anterior-posteri

61 h for mitral valve (MV) repair using a novel annuloplasty device placed in the coronary sinus.

62 The annuloplasty device reduced MR jet area from 5.4+/-2.6 t

63 Flexible annuloplasty devices used in mitral valve repair are, th

64 Mitral valve annuloplasty did not predict clinical outcome.

65 Therapy is uncertain because ring annuloplasty does not alleviate PM displacement.

66 Prevention of IMR by prophylactic ring annuloplasty does not influence remodeling.

67 We examined the impact of Paneth suture annuloplasty during acute IMR on motion of the mitral an

68 y 98 (8%) patients underwent tricuspid valve annuloplasty during follow-up.

69 Paneth suture annuloplasty eliminated acute IMR, and reduced septal-la

70 sis degeneration was observed in 7 cases and annuloplasty failure in 5.

71 (Mitralign Percutaneous Annuloplasty First in Man Study; NCT01852149).

72 opathic dilated cardiomyopathy who underwent annuloplasty for functional MR, basal mitral anterior le

73 Undersized ring annuloplasty for ischemic mitral regurgitation (MR) is a

74 Patients who undergo ring annuloplasty for ischemic mitral regurgitation (MR) ofte

75 ) versus early (3.8+/-5.8 months) after ring annuloplasty for ischemic MR during coronary artery bypa

76 1, 419 (65%) underwent concomitant tricuspid annuloplasty for moderate TR and/or tricuspid annular di

77 a strategy of routine concomitant tricuspid annuloplasty for moderate tricuspid regurgitation (TR) o

78 Catheter-based annuloplasty for secondary mitral regurgitation exploits

79 to 15 years underwent measured asymmetrical annuloplasty for severe mitral regurgitation in the year

80 saddle-shaped" mitral annulus, suggesting an annuloplasty for TR different from that for mitral regur

81 as significantly higher in the mesh than the annuloplasty group.

82 Mitral valve repair with annuloplasty has become a widely accepted technique for

83 Mitral valve repair with annuloplasty has become a widely accepted technique for

84 ), but its efficacy without concomitant ring annuloplasty has not been described in this setting.

85 Mitral valve annuloplasty improves hemodynamics and symptoms in these

86 edge-to-edge mitral repair performed without annuloplasty in degenerative mitral regurgitation (MR).

87 been reported after mitral valve repair with annuloplasty in patients with dilated cardiomyopathy, bu

88 The MV annuloplasty in this setting, without addressing fundame

89 We previously observed that undersized annuloplasty inhibited systolic wall thickening at the L

90 In this acute animal study, undersized annuloplasty inhibited systolic wall thickening in the a

91 In ischemic mitral regurgitation (IMR), ring annuloplasty is associated with a significant rate of re

92 Recurrent MR late after ring annuloplasty is associated with continued LV remodeling,

93 Percutaneous direct annuloplasty is feasible and safe in high-risk FMR patie

94 durability of tricuspid valve (TV) repair by annuloplasty is limited.

95 residual tricuspid regurgitation (TR) after annuloplasty is necessary to improve results of TV repai

96 Associated tricuspid annuloplasty is recommended during left-heart valve surg

97 Tricuspid valve (TV) annuloplasty is recommended for functional tricuspid reg

98 erative mitral repair, concomitant tricuspid annuloplasty is safe, effective, and associated with imp

99 ischemic mitral regurgitation with reduction annuloplasty is the current standard of practice, yet re

100 Although surgical annuloplasty is the standard repair for ischemic mitral

101 The procedure, "cerclage annuloplasty," is guided by magnetic resonance imaging (

102 This suggests that undersized mitral annuloplasty may have potentially deleterious effects on

103 s designed to assess effects of mitral valve annuloplasty (MVA) on mortality in patients with mitral

104 Percutaneous mitral annuloplasty (n = 7) acutely reduced MR (MR jet/LA area

105 The long-term effects of undersized annuloplasty on LV remodeling and function, however, wil

106 study, we measured the effects of undersized annuloplasty on regional transmural LV wall fiber and sh

107 ns of existing surgical approaches to mitral annuloplasty or leaflet repair.

108 alone and 92%, 74%, and 39% after CABG + MV annuloplasty (p = 0.6).

109 ximation with undersizing restrictive mitral annuloplasty (PMA) associated with complete surgical myo

110 nd chronic efficacy of a percutaneous mitral annuloplasty (PMA) device in experimental heart failure

111 Either type of ring annuloplasty prevented such changes, preserved papillary

112 While complete ring annuloplasty prevents acute IMR, partial annuloplasty ri

113 ischemic mitral regurgitation (IMR), because annuloplasty primarily addresses annular dilatation.

114 zed to either undersizing restrictive mitral annuloplasty (RA) or papillary muscle approximation with

115 Study 1: percutaneous mitral annuloplasty reduced annular dimension and severity of M

116 In the anterobasal region, undersized annuloplasty reduced systolic wall thickening (E33) by &

117 Percutaneous coronary sinus-based mitral annuloplasty reduces chronic IMR by reducing mitral annu

118 Although CABG + MV annuloplasty reduces postoperative MR and improves early

119 sis that recurrent MR in patients after ring annuloplasty relates to continued LV remodeling.

120 ons for and results of concomitant tricuspid annuloplasty remain controversial.

121 pact of TV deformations on the outcome of TV annuloplasty remains unknown.

122 leaflet tethering is invariable after mitral annuloplasty, rendering postoperative mitral competence

123 gitation frequently occurs after mitral ring annuloplasty repair for ischemic mitral regurgitation (I

124 The threshold for restrictive ring annuloplasty repair of secondary tricuspid regurgitation

125 Cardiac resynchronization and mitral annuloplasty represent potential nonpharmacologic therap

126 in conjunction with restrictive mitral valve annuloplasty represents the most efficacious treatment f

127 Percutaneous mitral annuloplasty results in acute and chronic reduction of f

128 nt of infected tissue and implantation of an annuloplasty ring (20 of 22 patients), as well as other

129 on (P=0.04) and the use of a complete mitral annuloplasty ring (P<0.0001) were associated with elevat

130 n=12), St Jude complete rigid saddle-shaped annuloplasty ring (RSA; n=10), Carpentier-Edwards Physio

131 LAMPOON was feasible in native and annuloplasty ring anatomies in patients who were otherwi

132 30%, received an undersized complete mitral annuloplasty ring as their MVR procedure.

133 We hypothesized that annuloplasty ring implantation alters mitral annular str

134 securely positioned Melody valves within the annuloplasty ring in all animals.

135 l valve (MV) repair with the CMA IMR ETlogix annuloplasty ring in patients with IMR.

136 of acute IMR, a partial, flexible posterior annuloplasty ring is as effective as a complete ring.

137 Carpentier-McCarthy-Adams (CMA) IMR ETlogix annuloplasty ring is the first remodeling ring specifica

138 Theoretically, such a flexible annuloplasty ring may provide better leaflet stress dist

139 Annuloplasty ring or band implantation during surgical m

140 Furthermore, neither annuloplasty ring perturbed the regional pattern of basa

141 The Tailor partial annuloplasty ring prevented acute IMR probably by limiti

142 MR with the novel asymmetric CMA IMR ETlogix annuloplasty ring provided excellent early results with

143 atients with severe MAC, prior failed mitral annuloplasty ring repair, or prior failed bioprosthetic

144 by post-operative dehiscence of the valve or annuloplasty ring resulting in clinically significant mi

145 On multivariable analysis, failed annuloplasty ring was independently associated with all-

146 surgery was associated with the use of a TV annuloplasty ring with a repair strategy (OR=0.40).

147 in selected patients with severe MAC, failed annuloplasty ring, and bioprosthetic MV dysfunction is a

148 age, complete heart block, MV repair without annuloplasty ring, and the degree of myxomatous degenera

149 eased significantly with rigid saddle-shaped annuloplasty ring, Carpentier-Edwards Physio, Edwards IM

150 underwent MV repair with the CMA IMR ETlogix annuloplasty ring.

151 In healthy, beating ovine hearts, annuloplasty rings (COS, RSA, PHY, ETL, and GEO) induce

152 prosthetic valves (valve-in-valve [ViV]) and annuloplasty rings (valve-in-ring [ViR]).

153 ical studies are needed to determine whether annuloplasty rings affect AML strains in patients, and,

154 Despite LAMPOON, TMVR using Sapien 3 in annuloplasty rings and MAC still exhibits important limi

155 Mitral annuloplasty rings are commonly used in MV repair proced

156 Proponents of flexible annuloplasty rings have hypothesized that such devices m

157 Whether annuloplasty rings maintain this relationship is unknown

158 ious studies have revealed that rigid mitral annuloplasty rings may be associated with left ventricul

159 ing annuloplasty prevents acute IMR, partial annuloplasty rings may offer a more physiologic repair,

160 ds Lifesciences, Irvine, California) TMVR in annuloplasty rings or native mitral annular calcificatio

161 bioprostheses, failed surgical repairs with annuloplasty rings or severe mitral annular calcificatio

162 Surgical repair with standard symmetric annuloplasty rings results in a high incidence of residu

163 Rigid annuloplasty rings should be used in favor of flexible b

164 ETlogix (ETL; n=11), and GeoForm (GEO; n=12) annuloplasty rings were implanted in a releasable fashio

165 R ETlogix (n=11), and Edwards GeoForm (n=12) annuloplasty rings were implanted in a releasable fashio

166 nts with degenerated bioprostheses or failed annuloplasty rings, but mitral ViR was associated with h

167 of three-dimensional shape, rigid, complete annuloplasty rings, but not a flexible, partial band, in

168 ults are less favorable in women with failed annuloplasty rings.

169 MV replacement in patients with preexisting annuloplasty rings.

170 Restrictive mitral valve annuloplasty (RMA) for secondary mitral regurgitation mi

171 icantly better in mesh-treated sheep than in annuloplasty sheep.

172 that in patients with TR secondary to AF, TV annuloplasty should be effective because this entity has

173 These results suggest that mitral annuloplasty should be the operation of choice in childr

174 rwent insertion of an adjustable Paneth-type annuloplasty suture and radiopaque markers on the LV and

175 itions, then before and after tightening the annuloplasty suture during proximal left circumflex occl

176 tightening an adjustable Paneth-type mitral annuloplasty suture.

177 mean+/-SD, P<0.05) by tightening the Paneth annuloplasty suture.

178 Tightening of the annuloplasty sutures, even beyond the degree necessary t

179 f the Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) Also Known as TriAlign [SCOU

180 The SCOUT (Percutaneous Tricuspid Valve Annuloplasty System for Symptomatic Chronic Functional T

181 om the feasibility study with a novel direct annuloplasty system.

182 Tricuspid valve annuloplasty (TA) during mitral valve repair (MVr) is as

183 eceive a procedure with or without tricuspid annuloplasty (TA).

184 tested a novel transcatheter circumferential annuloplasty technique to reduce mitral regurgitation in

185 A Paneth suture annuloplasty that could be reversibly tightened was anch

186 Ring annuloplasty, the standard treatment for ischemic mitral

187 Adding mitral annuloplasty to CABG in patients with moderate ischemic

188 al repair has been used clinically with ring annuloplasty to correct ischemic mitral regurgitation (I

189 ion procedures, such as rigid, complete ring annuloplasty, to address functional MR in patients with

190 Transcatheter tricuspid valve annuloplasty (TTVA) with the Cardioband system is a safe

191 d to sham surgery versus isolated undersized annuloplasty versus isolated bileaflet chordal cutting v

192 us treatment of mitral regurgitation (MR) by annuloplasty via CS is under development.

193 multivariate analysis showed that tricuspid annuloplasty was independently associated with freedom f

194 Annuloplasty was omitted in 36 patients because of heavy

195 Annuloplasty was performed in 88.8% of MV repair cases.

196 In a third group, a ring annuloplasty was placed before infarction to prevent IMR

197 ng the hydraulic formula of Gorlin, a mitral annuloplasty was tailored to the size of each patient so

198 Repair maneuvers in addition to annuloplasty were neochordae, leaflet resection, edge-to

199 TV tethering predicted residual TR after TV annuloplasty, whereas preoperative TV annular dimension

200 ute IMR can be achieved with a Paneth suture annuloplasty while simultaneously maintaining normal ann

201 Undersized mitral annuloplasty, widely used for ischemic and functional mi

202 II (n = 11) and III (n = 8) underwent mitral annuloplasty with either a semirigid or flexible ring, r

203 rmal hearts, during ischemia, and after ring annuloplasty with either type of ring.

204 discuss the emerging role of tricuspid valve annuloplasty with left ventricular assist device (LVAD)

205 illary muscle repair plus restrictive mitral annuloplasty with or without CABG (62.4%).

206 illary muscle repair plus restrictive mitral annuloplasty with or without CABG, based on SUCRA probab

207 lacing the rigid ring traditionally used for annuloplasty, with consequent further improvements in ve